Antipsychotic drugs and safety concerns for breast-feeding infants

Southern Medical Journal

Volumn 107, Issue 11, 2014, Pages 686-688

  Parikh, Tapan ^a,b,c,d   Goyal, Dharmendra ^a,b,c,d   Scarff, Jonathan R ^a,b,c,d   Lippmann, Steven ^a,b,c,d  

^a ROGOSIN INSTITUTE   (United States)

^b University of Louisville School of Medicine   (United States)

^c AUGUSTA UNIVERSITY   (United States)

^d Veterans Affairs Outpatient Clinic   (United States)

Author keywords

Antipsychotic drugs; Atypical antipsychotic medications; Breast feeding; Lactation; Typical antipsychotic agents

Indexed keywords

ARIPIPRAZOLE; ASENAPINE; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; ILOPERIDONE; LOXAPINE; LURASIDONE; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PERPHENAZINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; ZIPRASIDONE;

BREAST FEEDING; BREAST MILK; CASE STUDY; CHILD DEVELOPMENT; COHORT ANALYSIS; DEVELOPMENTAL DISORDER; DOSE RESPONSE; DRUG CHOICE; DRUG ELIMINATION; DRUG EXPOSURE; DRUG MILK LEVEL; DRUG MONITORING; DRUG SAFETY; HUMAN; INFANT; LOW DRUG DOSE; MENTAL DISEASE; PRESCRIPTION; PROSPECTIVE STUDY; PUERPERIUM; REVIEW; DRUG EFFECTS; FEMALE; METABOLISM;

ANTIPSYCHOTIC AGENTS; BREAST FEEDING; FEMALE; HUMANS; MILK, HUMAN;

EID: 84922393977     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.14423/SMJ.0000000000000190     Document Type: Review

References (32)

1. Usher K, Foster K, McNamara P. Antipsychotic drugs and pregnant or breastfeeding women: the issues for mental health nurses. J Psychiatr Ment Health Nurs 2005;12:713-718.
2. Winans EA. Antipsychotics and breastfeeding. J Hum Lact 2001;17:344-347.
3. Robinson GE. Treatment of schizophrenia in pregnancy and postpartum. J Popul Ther Clin Pharmacol 2012;19:e380-e386.
4. Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007;164:1817-1824.
5. Risbood V, Lee JR, Roche-Desilets J, et al. Lurasidone: an atypical antipsychotic for schizophrenia. Ann Pharmacother 2012;46:1033-1046.
6. Iqbal MM, Kunwar A, Lee K, et al. Effects of commonly used antipsychotics (typical and atypical) in pregnancy and lactation. J La State Med Soc 2005;157:94-97.
7. Gartner LM, Morton J, Lawrence RA, et al. Breastfeeding and the use of human milk. Pediatrics 2005;115:496-506.
8. Rubin ET, Lee A, Ito S. When breastfeeding mothers need CNS-acting drugs. Can J Clin Pharmacol 2004;11:e257-e266.
9. Tényi T, Csábi G, Trixler M. Antipsychotics and breast-feeding: a review of the literature. Paediatr Drugs 2000;2:23-28.
10. Yoshida K, Smith B, Craggs M, et al. Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychol Med 1998;28:81-91.
11. Wiles DH, Orr MW, Kolakowska T. Chlorpromazine levels in plasma and milk of nursing mothers. Br J Clin Pharmacol 1978;5:272-273.
12. Patton SW, Misri S, Corral MR, et al. Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk. Can J Psychiatry 2002;47:959-965.
13. Whalley LJ, Blain PG, Prime JK. Haloperidol secreted in breast milk. Br Med J (Clin Res Ed) 1981;282:1746-1747.
14. Olesen OV, Bartels U, Poulsen JH. Perphenazine in breast milk and serum. Am J Psychiatry 1990;147:1378-1379.
15. Lutz UC, Hiemke C, Wiatr G, et al. Aripiprazole in pregnancy and lactation: a case report. J Clin Psychopharmacol 2010;30:204-205.
16. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother 2004;38:1265-1271.
17. Barnas C, Bergant A, Hummer M, et al. Clozapine concentrations inmaternal and fetal plasma, amniotic fluid, and breast milk. Am J Psychiatry 1994;151:945.
18. Meyer JM, Loebel AD, Schweizer E. Lurasidone: a newdrug in development for schizophrenia. Expert Opin Investig Drugs 2009;18:1715-1726.
19. Sanford M. Lurasidone: in the treatment of schizophrenia. CNS Drugs 2013;27:67-80.
20. Croke S, Buist A, Hackett LP, et al. Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol 2002;5:243-247.
21. Whitworth A, Stuppaeck C, Yazdi K, et al. Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months. J Psychopharmacol 2010;24:121-123.
22. Brunner E, Falk DM, Jones M, et al. Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance. BMC Pharmacol Toxicol 2013;14:38.
23. Gardiner SJ, Kristensen JH, Begg EJ, et al. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry 2003;160:1428-1431.
24. Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 2000;20:399-403.
25. Rampono J, Kristensen JH, Ilett KF, et al. Quetiapine and breast feeding. Ann Pharmacother 2007;41:711-714.
26. Misri S, Corral M, Wardrop AA, et al. Quetiapine augmentation in lactation: a series of case reports. J Clin Psychopharmacol 2006;26:508-511.
27. Hill RC, McIvor RJ, Wojnar-Horton RE, et al. Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. J Clin Psychopharmacol 2000;20:285-286.
28. Ilett KF, Hackett LP, Kristensen JH, et al. Transfer of risperidone and 9-hydroxyrisperidone into humanmilk. Ann Pharmacother 2004;38:273-276.
29. Schlotterbeck P, Leube D, Kircher T, et al. Aripiprazole in human milk. Int J Neuropsychopharmacol 2007;10:433.
30. Gentile S. Infant safety with antipsychotic therapy in breast-feeding: a systematic review. J Clin Psychiatry 2008;69:666-673.
31. Klinger G, Stahl B, Fusar-Poli P, et al. Antipsychotic drugs and breastfeeding. Pediatr Endocrinol Rev 2013;10:308-317.
32. Iqbal MM, Aneja A, Rahman A, et al. The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation. Psychiatry (Edgmont) 2005;2:36-44.